tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VYGR Stock Latest News

Voyager Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
The FlyVoyager Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
7d ago
VYGR
Voyager Therapeutics Reports Increased Losses Amid Rising R&D Costs
PremiumCompany Announcements
Voyager Therapeutics Reports Increased Losses Amid Rising R&D Costs
8d ago
VYGR
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Justify Buy Rating
PremiumRatings
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Justify Buy Rating
9d ago
VYGR
Voyager Therapeutics files $400M mixed securities shelf
PremiumThe Fly
Voyager Therapeutics files $400M mixed securities shelf
9d ago
VYGR
Voyager Therapeutics price target lowered to $11 from $12 at Leerink
PremiumThe Fly
Voyager Therapeutics price target lowered to $11 from $12 at Leerink
9d ago
VYGR
Voyager Therapeutics reports Q3 EPS (47c), consensus (52c)
PremiumThe FlyVoyager Therapeutics reports Q3 EPS (47c), consensus (52c)
9d ago
VYGR
Voyager Therapeutics expects cash to fund operations into 2028
Premium
The Fly
Voyager Therapeutics expects cash to fund operations into 2028
9d ago
VYGR
Voyager Therapeutics, Transition Bio entered into drug discovery collab
Premium
The Fly
Voyager Therapeutics, Transition Bio entered into drug discovery collab
9d ago
VYGR
Voyager Therapeutics Advances Alzheimer’s Study with VY7523
PremiumCompany Announcements
Voyager Therapeutics Advances Alzheimer’s Study with VY7523
23d ago
VYGR
Voyager Therapeutics: Strategic Positioning and Regulatory Endorsements Drive Buy Rating
PremiumRatings
Voyager Therapeutics: Strategic Positioning and Regulatory Endorsements Drive Buy Rating
1M ago
VYGR
Voyager Therapeutics: Promising Alzheimer’s Portfolio and Innovative NeuroShuttle Platform Justify Buy Rating
PremiumRatings
Voyager Therapeutics: Promising Alzheimer’s Portfolio and Innovative NeuroShuttle Platform Justify Buy Rating
2M ago
VYGR
3 ‘Strong Buy’ Biotech Stocks Top Analysts Believe Have Over 300% Upside
PremiumMarket News
3 ‘Strong Buy’ Biotech Stocks Top Analysts Believe Have Over 300% Upside
3M ago
CGEM
TECX
Buy Rating for Voyager Therapeutics: Promising NeuroShuttle Platform and Strategic Growth Potential
PremiumRatingsBuy Rating for Voyager Therapeutics: Promising NeuroShuttle Platform and Strategic Growth Potential
3M ago
VYGR
Voyager Therapeutics Joins Citi’s Biopharma Conference 2025
Premium
Company Announcements
Voyager Therapeutics Joins Citi’s Biopharma Conference 2025
3M ago
8K
VYGR
Voyager Therapeutics: Strategic Positioning and Promising Pipeline Drive Buy Rating
Premium
Ratings
Voyager Therapeutics: Strategic Positioning and Promising Pipeline Drive Buy Rating
3M ago
VYGR
Voyager Therapeutics Extends Cash Runway to 2028
PremiumCompany Announcements
Voyager Therapeutics Extends Cash Runway to 2028
3M ago
VYGR
Voyager Therapeutics: Strategic Restructuring and Pipeline Progress Underpin Buy Rating
PremiumRatings
Voyager Therapeutics: Strategic Restructuring and Pipeline Progress Underpin Buy Rating
3M ago
VYGR
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating
PremiumRatings
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating
3M ago
VYGR
Voyager Therapeutics price target lowered to $8 from $9 at Wedbush
PremiumThe Fly
Voyager Therapeutics price target lowered to $8 from $9 at Wedbush
3M ago
VYGR
Voyager Therapeutics reports Q2 EPS (57c), consensus (52c)
PremiumThe FlyVoyager Therapeutics reports Q2 EPS (57c), consensus (52c)
4M ago
VYGR
Buy Rating for Voyager Therapeutics Driven by Promising Alzheimer’s Gene Therapy and Significant Share Price Potential
Premium
Ratings
Buy Rating for Voyager Therapeutics Driven by Promising Alzheimer’s Gene Therapy and Significant Share Price Potential
4M ago
VYGR
Voyager Therapeutics continues expansion of its AD franchise
Premium
The Fly
Voyager Therapeutics continues expansion of its AD franchise
4M ago
VYGR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >